Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
- PMID: 9771710
- DOI: 10.1038/2470
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
Abstract
Lafora's disease (LD; OMIM 254780) is an autosomal recessive form of progressive myoclonus epilepsy characterized by seizures and cumulative neurological deterioration. Onset occurs during late childhood and usually results in death within ten years of the first symptoms. With few exceptions, patients follow a homogeneous clinical course despite the existence of genetic heterogeneity. Biopsy of various tissues, including brain, revealed characteristic polyglucosan inclusions called Lafora bodies, which suggested LD might be a generalized storage disease. Using a positional cloning approach, we have identified at chromosome 6q24 a novel gene, EPM2A, that encodes a protein with consensus amino acid sequence indicative of a protein tyrosine phosphatase (PTP). mRNA transcripts representing alternatively spliced forms of EPM2A were found in every tissue examined, including brain. Six distinct DNA sequence variations in EPM2A in nine families, and one homozygous microdeletion in another family, have been found to cosegregate with LD. These mutations are predicted to cause deleterious effects in the putative protein product, named laforin, resulting in LD.
Similar articles
-
Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.Biochem Biophys Res Commun. 1999 Apr 2;257(1):24-8. doi: 10.1006/bbrc.1999.0402. Biochem Biophys Res Commun. 1999. PMID: 10092504
-
Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.Mol Cell Probes. 2001 Oct;15(5):281-9. doi: 10.1006/mcpr.2001.0371. Mol Cell Probes. 2001. PMID: 11735300
-
Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.J Hum Genet. 2003;48(1):51-4. doi: 10.1007/s100380300006. J Hum Genet. 2003. PMID: 12560877
-
[Molecular genetics of epilepsy].Rinsho Shinkeigaku. 2004 Nov;44(11):858-60. Rinsho Shinkeigaku. 2004. PMID: 15651314 Review. Japanese.
-
Advances in the genetics of progressive myoclonus epilepsy.Am J Med Genet. 2001 Summer;106(2):129-38. doi: 10.1002/ajmg.1575. Am J Med Genet. 2001. PMID: 11579433 Review.
Cited by
-
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme.Nat Commun. 2022 Oct 19;13(1):6199. doi: 10.1038/s41467-022-33693-z. Nat Commun. 2022. PMID: 36261419 Free PMC article.
-
Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.Mol Neurobiol. 2016 Mar;53(2):1296-1309. doi: 10.1007/s12035-015-9091-8. Epub 2015 Jan 28. Mol Neurobiol. 2016. PMID: 25627694 Free PMC article.
-
Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates.J Biol Chem. 2015 Sep 18;290(38):23361-70. doi: 10.1074/jbc.M115.658203. Epub 2015 Jul 31. J Biol Chem. 2015. PMID: 26231210 Free PMC article.
-
Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.Adv Drug Deliv Rev. 2021 Mar;170:425-438. doi: 10.1016/j.addr.2020.09.013. Epub 2020 Sep 28. Adv Drug Deliv Rev. 2021. PMID: 33002575 Free PMC article. Review.
-
Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinoses.Acta Neuropathol. 2024 Feb 27;147(1):46. doi: 10.1007/s00401-024-02698-x. Acta Neuropathol. 2024. PMID: 38411740
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials